Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.3B | 4.3B | 4.1B | 3.8B |
| Cost of revenue | 1.4B | 2.8B | 2.5B | 2.4B |
| Gross profit | 912M | 1.5B | 1.6B | 1.4B |
| Operating expense | ||||
| Research & development | 245M | 502M | 519M | 538M |
| Selling general and admin | 108M | 238M | 242M | 220M |
| Other operating expenses | — | — | — | — |
| Operating income | 559M | 776M | 790M | 595M |
| Non operating interest income | ||||
| Income | 10M | 11M | 9M | 9M |
| Expense | 91M | 95M | 99M | 103M |
| Other income expense | -404M | 49M | -72M | -399M |
| Pretax income | 74M | 741M | 628M | 102M |
| Tax provision | -698M | 147M | 135M | 63M |
| Net income | 524M | 594M | 493M | 39M |
| Basic EPS | 1.5 | 1.7 | 1.4 | 0.9 |
| Diluted EPS | 1.4 | 1.6 | 1.4 | 0.9 |
| Basic average shares | 389.7M | 387.4M | 385.2M | 372.9M |
| Diluted average shares | 400.8M | 399.7M | 399.7M | 390.8M |
| EBITDA | 680M | 880M | 910M | 722M |
| Net income from continuing op. | 520M | 594M | 493M | 39M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 13M | 9M | 8M | — |